IFNA1 and systemic lupus erythematosus: Thus, SLE is an extremely heterogeneous disease in all aspects, but recent studies have demonstrated characteristic induction of type I interferon-regulated genes (IFN-signature), which is linked to a more severe disease activity with organ failure, in patients with SLE (4–6).